Status:
COMPLETED
Tau PET Imaging in Atypical Dementias
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Primary Progressive Aphasia With Suspected Alzheimer's Disease
Eligibility:
All Genders
20-100 years
Phase:
PHASE1
Brief Summary
The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and to systematic...
Eligibility Criteria
Inclusion
- Must have primary progressive aphasia
Exclusion
- Pregnancy
- Breastfeeding
- Receiving radiation clinically
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03283449
Start Date
February 1 2016
End Date
February 28 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago - American School Building
Chicago, Illinois, United States, 60637